Stories & Ideas

Featured blog

5 Lessons Robotics Founders Can Learn From the AV Industry

Originally published in TechCrunch

Featured blog

ARTBIO: Redefining cancer care through an entirely new class of alpha radioligand therapies (ARTs)

There is a need for better isotopes to make ARTs that will enable transformati...

Featured blog

Why We Invested in Carrot Fertility: A global leader in fertility healthcare and family-forming

Carrot offers a more inclusive and exhaustive fertility-related benefit that c...

Stories & Ideas

By: F-Prime Capital

F-Prime’s Summer Internship Program: Meet our 2023 interns and fellows

By: F-Prime Capital

Behind the Breakthrough: Q&A with Emanuele Ostuni, ARTBIO

By: Rocio Wu

The RTP Gold Rush: 10 FedNow Predictions

Beam Therapeutics

The team developed a DNA base editing technology that enabled more precise edits...

By: Alex Pasteur, Ph.D., Martin Taylor, Ph.D.

ARTBIO: Redefining cancer care through an entirely new class of alpha radioligan...

By: Sanjay Aggarwal

Key Takeaways from Robotics Invest 2023

By: Shervin Ghaemmaghami, John Lin

Albert Invent’s $7.5M Seed Round

By: Carl Byers

Why We Invested in Carrot Fertility: A global leader in fertility healthcare and...

CHARM Therapeutics

Predicting the structure and nature of protein-ligand interactions could enable ...

By: Rocio Wu

There Are Gaps In The US Real-Time Payment System. Who Will Fill Them?

By: Sanjay Aggarwal

Robotics – Has the Time Finally Arrived for Venture Capital?

By: Rocio Wu

Toku Takes Flight: Revolutionizing Recurring Revenue Collection in LatAm

By: David Jegen

2022 Was The Calm Before The Storm For Tech Startups

By: David Jegen, John Lin, Rocio Wu, Abdul Abdirahman, Sarah Lamont

Assessing the State of Fintech

Denali Therapeutics

That needed to change. Through our affiliate FBRI, F-Prime has had a long-standi...

Equip

In 2019, Kristina Saffran and Dr. Erin Parks came to us with a slide deck and a ...

Prime Medicine

Using “search and replace” to address the fundamental causes of genetic disease.

By: David Jegen

Who Will Build the Bloomberg of Private Markets Data?

By: John Lin

Tracking the Disruptors With The F-Prime Fintech Index

By: Jay Farber

Introducing Ashby: The Data-Driven ATS

Peptone

Many human proteins are intrinsically disordered and play a critical role in key...

Orchard Therapeutics

But he only had a few pieces in hand. He and his co-founders had some of the mos...

Atalanta

Achieving broad distribution of RNAi therapeutics throughout the CNS has been a ...

By: John Lin, Abdul Abdirahman

Latchel: The Operating System for Property Management

By: John Lin, Betsy Mulé

Leading Mathison’s Series A to become the First All-In-One DEI Operating S...

By: Gaurav Tuli, Ben Gorman

Canary Technologies: Reinventing the Hotel Tech Stack

AviadoBio

Neurological disease remains the largest cause of disability and second leading ...

K36 Therapeutics

F-Prime has long been interested in precision medicine approaches that tackle th...

Flywire

International student was tasked with sending his international tuition payment ...

By: Sanjay Aggarwal

The Next Wave of Autonomous Vehicles

By: Gaurav Tuli

Announcing our Investment in Deal Engine

By: Abdul Abdirahman, David Jegen, John Lin, Sarah Lamont

Generational Shifts Drive New Fintech Innovation and Investment

By: Betsy Mulé

Influencers Are a New Class of Travel Agents — But Lack the Right Tools

Quovo

Lowell Putnam joins David Jegen to reflect on Quovo’s biggest wins

Ultragenyx

When he approached us, he was looking for an investor who would understand rare ...

Project Beacon

Boston’s life science community needed efficient, affordable, accessible and equ...

By: David Jegen, Abdul Abdirahman

The Alternative Asset Class Needs New Infrastructure — Who Will Build It?

Toast

Steve, Aman and Jon were at dinner when they realized the restaurant industry ne...

News

Nature

Peptone: finding opportunity in disorder

Wall Street Journal

All Pregnant Women Should Be Screened for Blood-Pressure Disorders, U.S. Advisers Say

Fierce Healthcare

Equip nabs additional investment to expand virtual eating disorder treatment services to adult patients

Globenewswire

Neumora Therapeutics Announces Pricing of Initial Public Offering

Newswire

Owkin and Tribun Health Launch Strategic Partnership to Accelerate Access to AI Solutions for Diagnosis and Pharma Research

Globenewswire

Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL